Evidence map›Paper›PMID 34525406›Full record

ArticleJournal of clinical epidemiology2022

Methodological challenges for living systematic reviews conducted during the COVID-19 pandemic: A concept paper.

Claire Iannizzi, Elena Dorando, Jacob Burns, Stephanie Weibel, Clare Dooley, Helen Wakeford, Lise J Estcourt, Nicole Skoetz, Vanessa Piechotta

Abstract read
In one paragraph

Article in Journal of clinical epidemiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. [Evidence syntheses in public health: An overview].Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Claire IannizziDepartment I of Internal Medicine, Evidence-based Oncology Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany. Electronic address: claire.iannizzi@uk-koeln.de.
Elena DorandoDepartment I of Internal Medicine, Evidence-based Oncology Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
Jacob BurnsBiometry and Epidemiology - IBE, LMU Munich , Institute for Medical Information Processing, Marchioninistr. 17, 81377, Munich, Germany; Pettenkofer School of Public Health, Munich, Germany.
Stephanie WeibelDepartment of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Wuerzburg, Germany.
Clare DooleyDepartment of Editorial and Methods, Cochrane Central Executive, London, UK.
Helen WakefordDepartment of Editorial and Methods, Cochrane Central Executive, London, UK.
Lise J EstcourtHaematology/Transfusion Medicine, NHS Blood and Transplant, John Radcliffe Hospital, Oxford UK, OX3 9BQ.
Nicole SkoetzDepartment I of Internal Medicine, Evidence-based Oncology Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
Vanessa PiechottaDepartment I of Internal Medicine, Evidence-based Oncology Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA living systematic review (LSR) is an emerging review type that makes use of continual updating. In the COVID-19 pandemic, we were confronted with a shifting epidemiological landscape, clinical uncertainties and evolving evidence. These unexpected challenges compelled us to amend standard LSR methodology. OBJECTIVE AND OUTLINE: Our primary objective is to discuss some challenges faced when conducting LSRs in the context of the COVID-19 pandemic, and to provide methodological guidance for others doing similar work. Based on our experience and lessons learned from two Cochrane LSRs and challenges identified in several non-Cochrane LSRs, we highlight methodological considerations, particularly with regards to the study design, interventions and comparators, changes in outcome measure, and the search strategy. We discuss when to update, or rather when not to update the review, and the importance of transparency when reporting changes. LESSONS LEARNED AND

conclusionWe learned that a LSR is a very suitable review type for the pandemic context, even in the face of new methodological and clinical challenges. Our experience showed that the decision for updating a LSR depends not only on the evolving disease or emerging evidence, but also on the individual review question and the review teams' resources.

Indexed as

COVID-19PandemicsHumansResearch DesignSystematic Reviews as TopicCOVID-19 pandemicEmerging diseaseExperience reportExperiences during pandemicLessons learnedLiving systematic review

Identifiers

PMID34525406
PMCPMC8435072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.